Boardroom Alpha
Meeting calendar
CLX · Annual meeting · Wednesday, November 18, 2026

Clorox Co

10 nominees · 3 ballot items.

Shareholders will vote on the election of 10 director nominees, an advisory approval of named executive officer compensation, and ratification of Ernst & Young LLP as the independent registered public accounting firm.

Market cap
$9.9B
1Y TSR
-25.2%
Board grade
C-
Record date
Sep 21, 2026
Filing
DEF 14A
Filed Oct 7, 2026 · DEF 14A
Proposals

On the ballot3

  1. 1

    Election of Directors

    ManagementBoard: FOR

    Elect the 10 director nominees named in the proxy statement to serve until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified.

  2. 2

    Advisory Vote to Approve Executive Compensation

    ManagementBoard: FOR

    Approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy statement, including the Compensation Discussion and Analysis and related compensation tables.

    More detail

    Proposal 2 asks shareholders to approve, on a non-binding advisory basis, the compensation paid to Clorox’s named executive officers for fiscal year 2026 and the compensation philosophy and practices described in the proxy statement. The resolution covers the overall NEO compensation program rather than any individual pay element. Clorox emphasizes that most executive compensation is at risk and tied to operational and long-term performance measures. The annual incentive plan uses net customer sales, net earnings attributable to Clorox, and gross margin, while long-term incentives rely substantially on economic profit performance share units and stock-price exposure. Fiscal 2026 incentive outcomes were below target, including a 54% annual incentive company multiplier and a 69% payout for the completed three-year PSU cycle. The company also disclosed one-time retention RSU awards to four executives in connection with the anticipated CEO transition and streamlined operating model, intended to preserve leadership continuity. Management notes that shareholders approved approximately 91% of the prior year’s say-on-pay proposal and says it continued its general compensation approach in fiscal 2026. The Board recommends a FOR vote because it believes the program effectively implements its pay-for-performance philosophy and aligns executive interests with sustainable shareholder value creation. Although advisory and non-binding, the vote provides the MDCC and Board with shareholder feedback, particularly if there is significant opposition.

  3. 3

    Ratification of the Selection of Ernst & Young LLP as Independent Registered Public Accounting Firm

    ManagementBoard: FOR

    Ratify the Audit Committee's selection of Ernst & Young LLP as Clorox's independent registered public accounting firm for the fiscal year ending June 30, 2027.

Director elections

Nominees on the ballot10

Independent
Tenure on this board
1.9 yrs
Also a director at
Target Corp (TGT)Yum Brands Inc (YUM)
Independent
Tenure on this board
1.9 yrs
Also a director at
Paccar Inc (PCAR)Southwest Airlines Co (LUV)
Independent
Tenure on this board
4.4 yrs
Also a director at
H&R Block Inc (HRB)Coty Inc (COTY)
Not independent
Tenure on this board
6.1 yrs
Also a director at
Visa Inc (V)
Independent
Tenure on this board
9.7 yrs
Also a director at
Dominos Pizza Inc (DPZ)
Independent
Tenure on this board
11.3 yrs
Also a director at
Ameriprise Financial Inc (AMP)Union Pacific Corp (UNP)
Ownership

Top institutional holders10

Latest 13F quarter
1STATE STREET CORP7.0%8,432,523$805M
2VANGUARD CAPITAL MANAGEMENT LLC6.5%7,896,390$754M
3VANGUARD PORTFOLIO MANAGEMENT LLC4.8%5,799,952$554M
4BlackRock, Inc.3.4%4,151,812$396M
5Invesco Ltd.2.6%3,184,944$304M
6GEODE CAPITAL MANAGEMENT, LLC2.4%2,863,136$272M
7BlackRock, Inc.2.3%2,751,069$263M
8VAN ECK ASSOCIATES CORP2.2%2,719,127$260M
9Invesco Ltd.2.1%2,486,389$237M
10MILLENNIUM MANAGEMENT LLC1.7%2,073,010$198M
Filings

Recent key filings

Periodic reports
Definitive proxies
Reference

Frequently asked questions

When is the Clorox Co 2026 annual meeting?
Clorox Co (CLX) holds its 2026 annual shareholder meeting on Wednesday, November 18, 2026.
What is the record date for the Clorox Co 2026 meeting?
The record date for the Clorox Co 2026 meeting is Monday, September 21, 2026. Shareholders of record on or before that date are eligible to vote.
Who are the director nominees for Clorox Co's 2026 meeting?
The board is presenting 10 director nominees at the Clorox Co 2026 meeting, listed with their independence status and background.
What proposals will shareholders vote on at the Clorox Co 2026 meeting?
Shareholders will vote on 3 proposals at the Clorox Co 2026 meeting, each tagged with who proposed it and the board's recommendation.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer